Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Pharmaceutical Desiccant Market

ID: MRFR/CnM/11407-HCR
100 Pages
Garvit Vyas
March 2026

US Pharmaceutical Desiccants Market Research Report Information By Type (Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves), By End-use (Tablets, API’s, Capsules, Nutraceutical Product Packaging), and By Region - Global Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Pharmaceutical Desiccant Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Application (USD Million)
  49.     4.1.1 Pharmaceutical Packaging
  50.     4.1.2 Pharmaceutical Manufacturing
  51.     4.1.3 Pharmaceutical Storage
  52.     4.1.4 Pharmaceutical Distribution
  53.   4.2 Chemicals and Materials, BY Type (USD Million)
  54.     4.2.1 Silica Gel
  55.     4.2.2 Molecular Sieves
  56.     4.2.3 Clay Desiccants
  57.     4.2.4 Calcium Sulfate
  58.   4.3 Chemicals and Materials, BY End Use (USD Million)
  59.     4.3.1 Tablets
  60.     4.3.2 Capsules
  61.     4.3.3 Injectables
  62.     4.3.4 Topicals
  63.   4.4 Chemicals and Materials, BY Material (USD Million)
  64.     4.4.1 Organic Desiccants
  65.     4.4.2 Inorganic Desiccants
  66.     4.4.3 Natural Desiccants
  67.   4.5 Chemicals and Materials, BY Form (USD Million)
  68.     4.5.1 Granules
  69.     4.5.2 Packets
  70.     4.5.3 Canisters
  71.     4.5.4 Sheets
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Desiccare Inc (US)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Sorbent Systems (US)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Clariant (US)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 W. R. Grace & Co. (US)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 Mitsubishi Chemical Corporation (US)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Sealed Air Corporation (US)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 BASF Corporation (US)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Hawkins Inc (US)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 US MARKET ANALYSIS BY APPLICATION
  142.   6.3 US MARKET ANALYSIS BY TYPE
  143.   6.4 US MARKET ANALYSIS BY END USE
  144.   6.5 US MARKET ANALYSIS BY MATERIAL
  145.   6.6 US MARKET ANALYSIS BY FORM
  146.   6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  147.   6.8 RESEARCH PROCESS OF MRFR
  148.   6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  149.   6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  150.   6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  151.   6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  152.   6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  153.   6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
  154.   6.15 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
  155.   6.16 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
  156.   6.17 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
  157.   6.18 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
  158.   6.19 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 (% SHARE)
  159.   6.20 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 TO 2035 (USD Million)
  160.   6.21 CHEMICALS AND MATERIALS, BY FORM, 2024 (% SHARE)
  161.   6.22 CHEMICALS AND MATERIALS, BY FORM, 2024 TO 2035 (USD Million)
  162.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  163. 7 LIST OF TABLES
  164.   7.1 LIST OF ASSUMPTIONS
  165.     7.1.1
  166.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  167.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  168.     7.2.2 BY TYPE, 2025-2035 (USD Million)
  169.     7.2.3 BY END USE, 2025-2035 (USD Million)
  170.     7.2.4 BY MATERIAL, 2025-2035 (USD Million)
  171.     7.2.5 BY FORM, 2025-2035 (USD Million)
  172.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  173.     7.3.1
  174.   7.4 ACQUISITION/PARTNERSHIP
  175.     7.4.1

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

  • Pharmaceutical Packaging
  • Pharmaceutical Manufacturing
  • Pharmaceutical Storage
  • Pharmaceutical Distribution

Chemicals and Materials By Type (USD Million, 2025-2035)

  • Silica Gel
  • Molecular Sieves
  • Clay Desiccants
  • Calcium Sulfate

Chemicals and Materials By End Use (USD Million, 2025-2035)

  • Tablets
  • Capsules
  • Injectables
  • Topicals

Chemicals and Materials By Material (USD Million, 2025-2035)

  • Organic Desiccants
  • Inorganic Desiccants
  • Natural Desiccants

Chemicals and Materials By Form (USD Million, 2025-2035)

  • Granules
  • Packets
  • Canisters
  • Sheets

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions